In addition, an increased expression level of miRNA-194 as well as blocked cell migration has been demonstrated in BC cell lines of those treated with trastuzumab, which shows the effect of tratuzumab on miRNA-194 expression, and its anti-tumor activity on HER2-overexpressing BC cell lines [21]. The gene discussed is ERBB2; the disease is neoplasm.